Healthcare -
Biotechnology - NASDAQ - US
$ 36.81
-7.48 %
$ 10.1 B
Market Cap
20.94
P/E
EXEL - REVENUE
Revenue EXEL - Exelixis, Inc.
2.17 B
LAST VALUE
16.02%
2 YEAR CAGR
17.51%
5 YEAR CAGR
56.18%
10 YEAR CAGR